Hims & Hers (HIMS) Jumps on Leadership Changes, Global Initiatives

We recently published 10 Hot Stocks Sparking Buying Frenzy. Hims & Hers Health Inc. (NYSE:HIMS) is one of the best performers on Tuesday.

Hims & Hers rallied for a second day on Tuesday, adding 5.86 percent to close at $57.97 apiece, as investors welcomed key leadership changes as part of the company’s global expansion initiatives.

In a social media post over the weekend, Hims & Hers Health Inc. (NYSE:HIMS) CEO Andrew Dudum named Mike Chi as the company’s new chief operating officer, leading operations, as well as product, marketing, and commercial segments. He will replace Nader Kabbani, who is stepping into a new advisory role focusing on global initiatives.

The changes will take effect on November 2, 2025.

“Nobody knows how to scale beloved tech and healthcare companies like Nader, and I’m excited for him to focus on future innovation. At the same time, Mike Chi, one of my most trusted partners, is taking on an expanded role,” Dudum said.

“Relentless operator, clear thinker, and builder of great teams. The right leader for this next chapter,” he noted.

Chi has been with Hims & Hers Health Inc. (NYSE:HIMS) since 2021, while Kabbani joined only in May 2025.

While we acknowledge the potential of HIMS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.